These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1377453

  • 1. Monocrotaline pyrrole alters DNA, RNA and protein synthesis in pulmonary artery endothelial cells.
    Hoorn CM, Roth RA.
    Am J Physiol; 1992 Jun; 262(6 Pt 1):L740-7. PubMed ID: 1377453
    [Abstract] [Full Text] [Related]

  • 2. Characterization of monocrotaline pyrrole-induced DNA cross-linking in pulmonary artery endothelium.
    Wagner JG, Petry TW, Roth RA.
    Am J Physiol; 1993 May; 264(5 Pt 1):L517-22. PubMed ID: 8498528
    [Abstract] [Full Text] [Related]

  • 3. Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cells.
    Hoorn CM, Roth RA.
    Br J Pharmacol; 1993 Oct; 110(2):597-602. PubMed ID: 8242234
    [Abstract] [Full Text] [Related]

  • 4. The response of pulmonary vascular endothelial cells to monocrotaline pyrrole: cell proliferation and DNA synthesis in vitro and in vivo.
    Lappin PB, Ross KL, King LE, Fraker PJ, Roth RA.
    Toxicol Appl Pharmacol; 1998 May; 150(1):37-48. PubMed ID: 9630451
    [Abstract] [Full Text] [Related]

  • 5. DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells.
    Wilson DW, Lamé MW, Dunston SK, Segall HJ.
    Toxicol Appl Pharmacol; 2000 Jul 15; 166(2):69-80. PubMed ID: 10896848
    [Abstract] [Full Text] [Related]

  • 6. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
    Lappin PB, Roth RA.
    Toxicol Pathol; 1997 Jul 15; 25(4):372-80. PubMed ID: 9280120
    [Abstract] [Full Text] [Related]

  • 7. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
    Hoorn CM, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1993 Jun 15; 120(2):281-7. PubMed ID: 8511798
    [Abstract] [Full Text] [Related]

  • 8. Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells.
    Thomas HC, Lamé MW, Dunston SK, Segall HJ, Wilson DW.
    Toxicol Appl Pharmacol; 1998 Aug 15; 151(2):236-44. PubMed ID: 9707500
    [Abstract] [Full Text] [Related]

  • 9. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
    Schultze AE, Roth RA.
    Toxicol Appl Pharmacol; 1993 Sep 15; 122(1):7-15. PubMed ID: 8378934
    [Abstract] [Full Text] [Related]

  • 10. Comparison of response of bovine and porcine pulmonary arterial endothelial cells to monocrotaline pyrrole.
    Reindel JF, Hoorn CM, Wagner JG, Roth RA.
    Am J Physiol; 1991 Dec 15; 261(6 Pt 1):L406-14. PubMed ID: 1767861
    [Abstract] [Full Text] [Related]

  • 11. Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNA.
    Thomas HC, Lamé MW, Wilson DW, Segall HJ.
    Toxicol Appl Pharmacol; 1996 Nov 15; 141(1):319-29. PubMed ID: 8917705
    [Abstract] [Full Text] [Related]

  • 12. Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pulmonary artery endothelial cells.
    Thomas HC, Lamé MW, Morin D, Wilson DW, Segall HJ.
    Am J Respir Cell Mol Biol; 1998 Jul 15; 19(1):129-42. PubMed ID: 9651189
    [Abstract] [Full Text] [Related]

  • 13. Monocrotaline pyrrole interacts with actin and increases thrombin-mediated permeability in pulmonary artery endothelial cells.
    Wilson DW, Lamé MW, Dunston SK, Taylor DW, Segall HJ.
    Toxicol Appl Pharmacol; 1998 Sep 15; 152(1):138-44. PubMed ID: 9772209
    [Abstract] [Full Text] [Related]

  • 14. Excess l-arginine restores endothelium-dependent relaxation impaired by monocrotaline pyrrole.
    Cheng W, Oike M, Hirakawa M, Ohnaka K, Koyama T, Ito Y.
    Toxicol Appl Pharmacol; 2005 Sep 15; 207(3):187-94. PubMed ID: 16129112
    [Abstract] [Full Text] [Related]

  • 15. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
    Schultze AE, Emeis JJ, Roth RA.
    Biochem Pharmacol; 1996 Jan 26; 51(2):187-91. PubMed ID: 8615888
    [Abstract] [Full Text] [Related]

  • 16. The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.
    Reindel JF, Roth RA.
    Am J Pathol; 1991 Mar 26; 138(3):707-19. PubMed ID: 2000943
    [Abstract] [Full Text] [Related]

  • 17. Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging.
    Lee J, Reich R, Xu F, Sehgal PB.
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct 26; 297(4):L715-28. PubMed ID: 19648287
    [Abstract] [Full Text] [Related]

  • 18. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
    Roth RA, Reindel JF.
    Adv Exp Med Biol; 1991 Oct 26; 283():477-87. PubMed ID: 1906225
    [Abstract] [Full Text] [Related]

  • 19. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
    Schultze AE, Gunaga KP, Wagner JG, Hoorn CM, Moorehead WR, Roth RA.
    Toxicol Appl Pharmacol; 1994 Jun 26; 126(2):301-10. PubMed ID: 8209383
    [Abstract] [Full Text] [Related]

  • 20. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells.
    Taylor DW, Wilson DW, Lamé MW, Dunston SD, Jones AD, Segall HJ.
    Toxicol Appl Pharmacol; 1997 Mar 26; 143(1):196-204. PubMed ID: 9073608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.